Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Septerna, Inc.NASDAQ: SEPN
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables rises 61.1% from a year ago
Net receivables stood at $18.88M at the end of Q3 FY2026, up 61.1% from a year earlier and up 18.5% from the prior quarter.
Context
- Net receivables amounted to 3.0% of total assets at the end of Q3 FY2026, up 1.1 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +61.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 13.74M USD
- Year-over-year change
- +1122.4%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.74M | +1122.4% |
| FY2024 | 2024-12-31 | 1.12M | -95.1% |
| FY2023 | 2023-12-31 | 22.78M | — |
| FY2022 | 2022-12-31 | 0 | — |
Net Receivables vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 net receivables of $18.88M is the 2nd highest of the 7 companies compared; the peer median is $0.
- Its year-over-year change of +61.1% is the 2nd highest of 3, against a peer median of +4.4%.
- Net receivables amounts to 3.0% of total assets for SEPN, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $20M | — | — | 4.8% | |
SEPNSepterna, Inc. | Sep 2026 | $18.88M | +61.1% | — | 3.0% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $3.23M | +108.7% | +146.2% | 0.6% |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $0 | — | — | 0.0% |
| Jun 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding SEPN) | $0 | +4.4% | +146.2% | 0.0% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.